SUDBURY, ON – HSNRI Scientist, Dr. Carole Mayer, RSW will be presenting at the Annual American Society of Clinical Oncology (ASCO) 2018 Annual Meeting to be held in Chicago June 1-5, 2018 as an invited Education Faculty Member.
Dr. Mayer will be part of a panel presenting on the Psychosocial Needs of Cancer Survivors and Best Practices for Distress Screening. She has also co-authored and article published in the ASCO Educational Book, Delivering Discoveries: Expanding the Reach of Precision Medicine, A Peer-Reviewed, Indexed Publication addressing best practices in oncology for distress management.
“We know from emerging evidence that distress screening with patient reported outcome measures is associated with improved communication between clinicians and cancer patients, improved quality of life with emerging evidence associated with improved survival”, says Dr. Carole Mayer, Scientist at HSNRI and Director of Research and Regional Clinical Lead, Supportive Care Oncology Program, Health Sciences North. “It also has potential to reduce the impact on the health system by decreasing visits to emergency departments”.
Since 2009, Dr. Mayer’s research has focused on the implementation of screening for distress programs in Northeastern Ontario using principles of participatory action research methods, scientific implementation, knowledge translation and change management strategies. In Canada Screening for Distress is recognized as the 6th Vital Sign and a standard of care for any Canadian organization wishing to be accredited for their cancer program.
“Screening for distress is important for any patient throughout their cancer journey. Dr. Carole Mayer’s research has allowed for the implementation of screening for distress for cancer patients across the Northeast and assisted them to find the necessary supports in their community. Congratulations to Dr. Mayer and her research team are who being recognized internationally for best practices in screening for distress”, says Mark Hartman, Vice President of Cancer Services and Clinical Support.
Dr. Mayer who is also President of the national Canadian Association of Psychosocial Oncology (CAPO) will be participating in a symposium with other researchers in Canada for the latest updates in the field for Screening for Distress (the 6th Vital Sign) and Patient Reported Outcome Measures, scheduled at the annual conference from May 30 to June 1, 2018 in Toronto.